11th Annual Clinical Trials in Oncology West Coast 2024

The West Coast's leading Clinical Trials in Oncology Conference showcasing the most efficient methods, strategizes and solutions of running oncology trials.

23 - 24

April

2024
  • San Francisco Airport Marriott Waterfront, USA
  • Complimentary
  • Why attend?
  • Agenda
  • Speakers
  • Plan Your Visit
  • Sponsors
  • Media Centre
  • Why partner?
  • Contact Us
close

Why attend?

WHAT TO EXPECT FOR 2024?

What do we have for 2024?

We have introduced and dedicated a whole new stream on patient recruitment and engagement which focuses on harnessing strategizes, communication and latest trends in Oncology clinical trials. The event will include the top industry experts to share their latest struggles and successes.

 

250+

Attendees

20+

Exhibitors

20+

Speakers

250+

Attendees

20+

Exhibitors

20+

Speakers

See What It's All About

Agenda

  • 23 Apr 2024
  • 24 Apr 2024
Expand All

Streams

Stream one

STREAM A: Clinical Operations

Stream two

STREAM B: Patient Recruitment and Engagement

11:30 AM

How patient engagement in real world practice informs or relates to patient engagement efforts on development side

  • Exploring real-world data and evidence collected from patient engagement initiatives to inform development of clinical trials
  • Importance of patient care and discussing how patient engagement promotes better clinical trial outcomes
  • How digital tools, apps and telemedicine can enhance patient engagement and communications

Speakers

Nancy Paynter
Head Global Medical Affairs Strategy, Planning & Insights, Gilead

12 PM

Reserved for Precision for Medicine

12:30 PM

Giving back to the community: Decentralized clinical trials and home nursing options to bring trials to patients’ home

  • How can we bring oncology trials to patients in their homes, and what are the benefits for patients?
  • What is stopping sponsors from enabling drugs to be sent to local pharmacies and homes?
  • Re-evaluating current budgets to execute DCT trials in oncology

Speakers

Oscar Segurado
Chief Medical Officer, ASC Therapeutics

1 PM

Reserved for tech spotlight event sponsor

1:15 PM

Lunch and networking

2:15 PM

Panel discussion: Building trust with patients in oncology clinical trials

  • Reviewing current communication between patients, sites and trial sponsors: where is there room for improvement?
  • Establishing real experience of patients to gain trust within trials
  • Investigating how to grow trust with patients from underrepresented communities and include into oncology clinical trials
  • Reviewing how to ethically build trust of patients and optimize oncology clinical trials

Speakers

Cameron McClure
Associate Director Global Clinical Trial Diversity, BeiGene
Mamta Thakker
Director of Clinical Operations, Pliant Therapeutics
Bill Paseman
Co-founder of Rarekidneycancer and patient advocate
Christine Von Raesfeld
Founder and CEO, People with Empathy

2:45 PM

Reserved for TFS Healthscience

3:15 PM

How are sponsors enhancing strategies for patient enrollment?

  • Examining current strategies and challenges in enrollment: how to grow patient numbers for your oncology trial
  • Investigating Project Equity and Project ASIATICA, and their implementation in clinical trial recruitment
  • Identifying frameworks and designing new ways to enroll patients for oncology trials

Speakers

Radha Duttagupta
Vice President Clinical Affairs, Nucleix

3:45 PM

Afternoon refreshments and networking

4:15 PM

How can you improve diversity and inclusion in your trial by working closely with local communities?

  • How are companies currently adhering to the Race and Ethnicity Diversity Plan?
  • Optimizing clinical trial efficiency and drug development by adhering to Depict Act
  • How to improve enrollment in oncology clinical trials from underrepresented racial and ethnic populations

Speakers

Tania Szado
Principal Oncology Medical Science Director, US Medical Affairs, Scientific Collaborations & Alliances, Genentech
Patricia Mader
Executive Director, US Medical Affairs and Head of Evidence Generations Oncology, Genentech

4:45 PM

Reserved for event sponsor

5:15 PM

Fireside chat: Emphasizing importance of minimizing patient burden in oncology trials

  • Examining barriers preventing patients’ participation in oncology trials
  • Empathizing with patients’ experience and how we can reflect to improve patient care
  • Discussing how to enhance quality of life for patients and potential solutions to lessen burden of trial participation

Moderator: Christine Von Raesfeld

Speakers

Arla Yost
Clinical Research Operations Director, Helen Diller Family Comprehensive Cancer Center, University of California
Christine Von Raesfeld
Founder and CEO, People with Empathy

8 AM

Registration and refreshments

8:50 AM

Chairperson’s opening remarks

Speakers

Jasminemay Barcelon
Analyst Research and Analysis, GlobalData

9 AM

KEYNOTE: UCSF IRB’s Review of Oncology Trials: Streamlining Review and Approval

  • Benefits of using UCSF IRB for reviews of oncology research
  • Describing how UCSF new consent form and process of inviting investigators to IRB meetings have been successful at streamlining review and approval of oncology studies.
  • What can sponsors do to improve IRB time to approval?

Speakers

Jason Keenan
Associate Director, Full Committee Reviews, Institutional Review Board, University of California San Francisco

9:30 AM

Reserved for Mercalis

10 AM

KEYNOTE: Understanding what it is like living with cancer while participating in a clinical trial: where can the burden on patients be lightened?

  • How living with cancer impacts ability to participate in clinical trials and what can be done to relieve burden on patients
  • Insights into a patient’s trial experience while undergoing multiple tests for their illness
  • How to alleviate financial burden on patients participating in oncology trials
  • Focusing on protecting patient data and security during trials

Speakers

Christine Von Raesfeld
Founder and CEO, People with Empathy
Bill Paseman
Co-founder of Rarekidneycancer and patient advocate

10:30 AM

Maximizing the consultative partnership between CRO and biotech sponsors

  • Leveraging early engagement to improve outcomes
  • Speaking the same language – one size actually doesn’t fit all
  • Mapping a development pathway with the end in mind

Speakers

Leslie Grimes
Executive Director, Project Delivery, ICON Biotech

11 AM

Morning refreshments and networking

11:30 AM

Site management and site relationships in oncology trials

  • Highlighting importance of site management to increase trial success
  • Evaluating struggles in site relationships and what are the solutions to streamline selection and balance relations?
  • Investigating strategies to maximize patient recruitment at selected sites

Speakers

Mamta Thakker
Director of Clinical Operations, Pliant Therapeutics
Kanyetta Wansley
Director of Site Liaison, Pliant Therapeutics

12 PM

Reserved for Worldwide Clinical Trials

12:30 PM

How can we advantageously use AI to improve data management and reporting?

  • Evaluating how the industry is currently managing data and reporting for clinical trials
  • Looking at successful implementations of AI and where the industry can adapt
  • Analyzing risks and opportunities of using AI to report and manage data

Speakers

Harit Nandani
Director, Clinical Data Management, GRAIL

1 PM

Reserved for tech spotlight eClinical Solutions

1:15 PM

Lunch and networking

2:15 PM

Panel discussion: Evaluating current research and clinical trends in clinical operations for oncology trials

  • Discussing clinical trends and developments in oncology trial research
  • Analyzing current strategies and ways to increase clinical patient beneficial results in oncology trials
  • How sponsors can navigate new regulations amidst current restrictions in clinical cancer trials

Moderator: Jasminemay Barcelon

Speakers

Oscar Segurado
Chief Medical Officer, ASC Therapeutics
David. A Zarling
Chief Executive Officer, Colby Pharmaceuticals
Tariq Arshad
Chief Medical Officer, Qualigen Therapeutics
Jasminemay Barcelon
Analyst Research and Analysis, GlobalData

2:45 PM

Session reserved for Scimega Research, Inc.

3:15 PM

Reframing complex oncology trials to reduce delayed operations and drug development

  • How are oncology trials becoming more complex and in what manner is it impacting drug development?
  • Investigating risks and opportunities of changing frameworks of oncology clinical trials
  • How are we reporting and managing data and what is needed to efficiently organize large oncology trials?

Speakers

Shantheri Pai
Associate Director - Clinical Operations, Oncology, Gilead

3:45 PM

Afternoon refreshments and networking

4:15 PM

Top tips, tricks, and best practices in order to ensure immuno-oncology trials are successful

  • Generating clinical strategies that are long-term and durable to personalize anti-tumor responses
  • Priming and maintaining immune responses by therapeutic and preventative anti-cancer vaccine sequential injections into lymphoid and other tissues
  • Counter-regulating tumor microenvironment without manipulation of the genome
  • Advances in new therapeutic and companion diagnostic clinical trials with intralymphatic oncology vaccines
  • Lymph Node and other targeted delivery of immunomodulatory agents including: RNA-encoded antigenic epitopes, cytokines, antibodies, immune cells

Speakers

David. A Zarling
Chief Executive Officer, Colby Pharmaceuticals

4:45 PM

Reserved for PSI CRO

5:15 PM

Fireside chat: How to maintain a great relationship with CROs when running an oncology trial

  • Highlighting common issues between sponsors and vendors to maintain a better relationship
  • Emphasizing importance on trust and communication to enhance results from CROs
  • What foundations do sponsors require from CROs to obtain an effective partnership?

Moderator: Jasminemay Barcelon

Speakers

Tariq Arshad
Chief Medical Officer, Qualigen Therapeutics
Jasminemay Barcelon
Analyst Research and Analysis, GlobalData

5:45 PM

Chairperson’s closing remarks

END OF DAY 1 AND NETWORKING DRINKS

Networking drinks reception

8 AM

Registration and refreshments

8:50 AM

Chairperson’s opening remarks

9 AM

PROBLEM-SOLVING ROUNDTABLE DISCUSSIONS

During the roundtable discussion session, the conference hall will be divided into four ‘zones’. Delegates can choose which zone they would like to join. Each zone will be led by a table moderator and will focus on a different challenge within oncology clinical trials. After 45 minutes, delegates will have the opportunity to swap and choose a different table, and each roundtable will run twice.

ROUNDTABLE 1: Discussing how sponsors can maximize patient recruitment including ethnic minorities in present US market climate

Cameron McClure, Associate Director, Global Clinical Operations, Clinical Trial Diversity, BeiGene

ROUNDTABLE 2: Finding the right protocol design and using right data to leverage oncology trials

Jill Hacker, Director of Data Management, InstilBio

ROUNDTABLE 3: Focusing on patient centricity and how sponsors are creating better patient experience?

Christine Von Raesfeld, Founder and CEO, People with Empathy

ROUNDTABLE 4: Improving outcomes by tailoring cancer therapy for patients without targetable mutations

Chris Apfel, CEO and Chairman, SageMedic Corporation

Speakers

Cameron McClure
Associate Director Global Clinical Trial Diversity, BeiGene
Jill Hacker
Director Data Management, Instil Bio
Christine Von Raesfeld
Founder and CEO, People with Empathy
Dr Chris Apfel
CEO and Chairman, SageMedic Corp

10:30 AM

Morning refreshments and networking

11 AM

Fireside chat: How can small biotechs secure investments to carry out research and diagnostics in the long-term?

  • Investigating how venture capitalists can aid sponsors with oncology trials in the long term
  • Exploring avenues available to sponsors in order to source investment for oncology trials
  • How can sponsors strategize new ways to attract investors for research and oncology trial development?

 

Speakers

David Schuster
Managing Partner, UpScalerVC

11:30 AM

Reserved for RadMD

12 PM

Translational learnings and opportunities in cell and gene therapy for the treatment of cancer

• Exploring new modalities and platforms to support new generation gene and cell therapies
• What can we learn from current clinical and translational evidence thus far from cell therapies that were successful?
• Determining whether cell and gene therapies are the best solutions to implement in specific oncology indications

Speakers

Vicki Plaks
Senior Scientific Director, Head of Cell Therapy, Oncology Translational Research, Johnson & Johnson

12:30 PM

Lunch, networking, and prize draw!

1:25 PM

EXHIBITION APPLE PRIZE DRAW

Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple devices or Amazon vouchers. The Prize Draw will take place in the Exhibition Hall, make sure you don’t miss out!

1:30 PM

Fireside chat: A real-world evidence decentralized clinical care study to tailor cancer therapy

  • Tailoring cancer therapy by complementing genomic testing with the Sage Oncotest™
  • Creating evidence from real-world clinical applications
  • Aligning interests for all stakeholders: patients, providers, researchers, and payers

Moderator: Jasminemay Barcelon

Speakers

Dr Chris Apfel
CEO and Chairman, SageMedic Corp
Jasminemay Barcelon
Analyst Research and Analysis, GlobalData

2 PM

Reserved for event sponsor

2:30 PM

Patient recruitment: Trends in trials that got it right

• Highlighting trends in trial designs used within oncology trials that successfully met their recruitment targets.
• Exploring the effect of trial design on subject drop-out rates and comparing drop-out rates in the East Coast to global trials through case studies.
• Using historical oncology trial data to explore the difference between the ratio of subjects to sites in completed vs terminated oncology trials.
• Using case studies to compare the project outlook, timelines, and expected enrolment, between the East Coast and global oncology trials.

Speakers

Sonnika Lamont
Analyst, Clinical Trials Intelligence, GlobalData

3 PM

Chairperson’s closing remarks

END OF CONFERENCE

Speakers

Select a speaker to learn more

Back
Jasminemay Barcelon
Analyst Research and Analysis, GlobalData

Jasminemay Barcelon, MSc, is an Analyst of Oncology and Hematology at GlobalData in the UK. Jasminemay graduated from the University of California, Los Angeles in Physiological Sciences / Pre-Medicine with three years' experience as a physician partner in obstetrics and gynecology and gynecology oncology publishing case studies on vaginal sarcoma in pregnancy and treatment of gestational trophoblastic neoplasia. She was concurrently a lead clinical trial coordinator for four Phase III clinical trials at UCLA gaining a breadth of knowledge on clinical trial design, patient monitoring, and regulatory reporting.  She holds a Master of Science in Cancer & Molecular and Cellular Biology from the Bart's Cancer Institute with research focused on targeting chemoresistance in high-grade serous ovarian cancer. Jasminemay is passionate about data-driven insights and developing strategies to target unmet needs in oncology.

Session Details:

Chairperson’s opening remarks

2024-04-23, 8:50 AM

Session Details:

Panel discussion: Evaluating current research and clinical trends in clinical operations for oncology trials

2024-04-23, 2:15 PM

Session Details:

Fireside chat: A real-world evidence decentralized clinical care study to tailor cancer therapy

2024-04-24, 1:30 PM

Session Details:

Fireside chat: How to maintain a great relationship with CROs when running an oncology trial

2024-04-23, 5:15 PM

View In Agenda
Next speaker
Back
Christine Von Raesfeld
Founder and CEO, People with Empathy

Christine Von Raesfeld (she/her), founder and CEO of People with Empathy (PwE), is a pillar of patient advocacy and allyship in the rare and chronic disease community. Through the lens of her lived experiences in health care, she has become a champion for patient voices, diversity and inclusion in clinical research, and equitable patient–sponsor partnerships.

Christine has brought her unique perspective and honed expertise as a featured speaker for numerous conferences on topics ranging from clinical trial recruitment to data and digital rights, from a true patient perspective. She serves as an e-patient scholar with Stanford Medicine X and a Technical Expert Panelist with the Centers for Medicare & Medicaid Services (CMS), among other roles. Wherever possible, Christine generates momentum toward progress around her patient advocacy interests, and she has become a thought leader worldwide, stimulating dialog on a range of topics relevant to patients, clinicians, and industry as moderator and host of People with Empathy: The Inside Track on Clubhouse.

Session Details:

KEYNOTE: Understanding what it is like living with cancer while participating in a clinical trial: where can the burden on patients be lightened?

2024-04-23, 10:00 AM

Session Details:

PROBLEM-SOLVING ROUNDTABLE DISCUSSIONS

2024-04-24, 9:00 AM

Session Details:

Panel discussion: Building trust with patients in oncology clinical trials

2024-04-23, 2:15 PM

Session Details:

Fireside chat: Emphasizing importance of minimizing patient burden in oncology trials

2024-04-23, 5:15 PM

View In Agenda
Next speaker
Back
Jason Keenan
Associate Director, Full Committee Reviews, Institutional Review Board, University of California San Francisco

Jason Keenan, MS, CIP is the UCSF IRB Associate Director of Full Committee Reviews. In his 10 years at the UCSF IRB, Jason has been part of the review of dozens of oncology clinical trials. In the past two years, the UCSF IRB streamlined the review process for oncology clinical trials, resulting in faster times to approval. The presentation will cover the steps the IRB took to accomplish this goal.

Session Details:

KEYNOTE: UCSF IRB’s Review of Oncology Trials: Streamlining Review and Approval

2024-04-23, 9:00 AM

View In Agenda
Next speaker
Back
Tania Szado
Principal Oncology Medical Science Director, US Medical Affairs, Scientific Collaborations & Alliances, Genentech

Session Details:

How can you improve diversity and inclusion in your trial by working closely with local communities?

2024-04-23, 4:15 PM

View In Agenda
Next speaker
Back
Patricia Mader
Executive Director, US Medical Affairs and Head of Evidence Generations Oncology, Genentech

Session Details:

How can you improve diversity and inclusion in your trial by working closely with local communities?

2024-04-23, 4:15 PM

View In Agenda
Next speaker
Back
Shantheri Pai
Associate Director - Clinical Operations, Oncology, Gilead

Session Details:

Reframing complex oncology trials to reduce delayed operations and drug development

2024-04-23, 3:15 PM

View In Agenda
Next speaker
Back
Nancy Paynter
Head Global Medical Affairs Strategy, Planning & Insights, Gilead

Session Details:

How patient engagement in real world practice informs or relates to patient engagement efforts on development side

2024-04-23, 11:30 AM

View In Agenda
Next speaker
Back
Vicki Plaks
Senior Scientific Director, Head of Cell Therapy, Oncology Translational Research, Johnson & Johnson

Session Details:

Translational learnings and opportunities in cell and gene therapy for the treatment of cancer

2024-04-24, 12:00 PM

View In Agenda
Next speaker
Back
Harit Nandani
Director, Clinical Data Management, GRAIL

Harit Nandani has 12+ years of experience in clinical trials data and technology leadership for both diagnostics and therapeutic trials. He specializes in clinical trial data management and analysis, configuring systems for population-scale studies, and using analytics tools to monitor projects. Currently, he is the Director of Clinical Data Management at GRAIL, overseeing data and systems for trials in the UK and US supporting early cancer detection diagnostics development. He has worked on projects enrolling over 300,000 participants, leading to the development of the Galleri test, which has detected over 50 types of cancer and has been named one of TIME Magazine's best inventions and The Atlantic's 10 most promising breakthroughs of 2022. Prior to GRAIL, Harit led late-stage pivotal trials in Oncology at Gilead Sciences and worked in various clinical research roles at a CRO and a small biopharmaceutical development company.

Session Details:

How can we advantageously use AI to improve data management and reporting?

2024-04-23, 12:30 PM

View In Agenda
Next speaker
Back
Dr Chris Apfel
CEO and Chairman, SageMedic Corp

Dr. Chris Apfel is the founder and CEO of SageMedic Corp., an early-stage clinical diagnostics company to assist oncologists in selecting the most effective treatment for their patients. Dr. Apfel is also the Chair of Life Sciences at the Keiretsu Angel Investment Forum, where he invests in life-science companies that have the potential to positively impact patients with serious conditions. Prior to starting SageMedic, he was an Associate Professor at UCSF. Dr. Apfel is an internationally known authority on designing, conducting, and publishing highest quality clinical trials with thousands of patients that have changed medical practice with over 100 peer-reviewed publications. Dr. Apfel is a California licensed physician with 20+ years of clinical experience in anesthesiology, critical care medicine, and emergency medicine. He received his medical degree (MD) and his doctoral degree (PhD equivalent) from Justus-Liebig-Universität Giessen, Germany, and his Master of Business Administration (MBA) from the Wharton School of Business, University of Pennsylvania, PA

Session Details:

PROBLEM-SOLVING ROUNDTABLE DISCUSSIONS

2024-04-24, 9:00 AM

Session Details:

Fireside chat: A real-world evidence decentralized clinical care study to tailor cancer therapy

2024-04-24, 1:30 PM

View In Agenda
Next speaker
Back
David Schuster
Managing Partner, UpScalerVC

AVenture Capitalist and Private Equity Investor, identified/evaluated investment opportunities by analyzing market trends, conducting due diligence, and assessing the companies' financial viability and growth potential. Furthermore, thrived on identifying untapped opportunities, disrupting traditional business models, and spearheading change that positively impacts the bottom lines; and have consistently driven revenue growth, expanded market share, and enhanced overall business performance by leveraging emerging technologies and implementing forward-thinking strategies. As a collaborative leader, they fostered a culture of excellence, encouraging team members to think creatively and take ownership of their projects.

Session Details:

Fireside chat: How can small biotechs secure investments to carry out research and diagnostics in the long-term?

2024-04-24, 11:00 AM

View In Agenda
Next speaker
Back
Cameron McClure
Associate Director Global Clinical Trial Diversity, BeiGene

Cameron McClure, Associate Director of Clinical Trial Diversity within Global Clinical Operations, BeiGene

Cameron McClure is an Associate Director of Clinical Trial Diversity within Global Clinical Operations at BeiGene. Prior to this role he has had several leadership positions within Clinical Business Operations overseeing site contracts, budgets, payments, and a team of Business and Data Analysts.  Cameron has worked in Academia for institutions such as Stanford University and Emory University in Clinical Research Finance and began his career at Morehouse School of Medicine as a Clinical Research Coordinator. He is an agile project manager, a leader, and a visionary with a focus on process improvement through innovation.  He currently resides in Long Beach, CA with his family and enjoys traveling, music production, and learning.

Session Details:

PROBLEM-SOLVING ROUNDTABLE DISCUSSIONS

2024-04-24, 9:00 AM

Session Details:

Panel discussion: Building trust with patients in oncology clinical trials

2024-04-23, 2:15 PM

View In Agenda
Next speaker
Back
Arla Yost
Clinical Research Operations Director, Helen Diller Family Comprehensive Cancer Center, University of California

Arla Yost, Clinical Research Operations Director, Helen Diller Family Comprehensive Cancer Center, UCSF

Arla holds an MSc in Interdisciplinary Oncology and is both CCRP and PMP certified. She has worked in healthcare and oncology for almost 15 years, with the last 7 years spent focused on clinical research operations at UCSF’s NCI-designated Comprehensive Cancer Center.

Session Details:

Fireside chat: Emphasizing importance of minimizing patient burden in oncology trials

2024-04-23, 5:15 PM

View In Agenda
Next speaker
Back
Oscar Segurado
Chief Medical Officer, ASC Therapeutics

Chief Medical Officer at ASC Therapeutics, a biopharma company focusing on gene editing and gene therapy for Hemophilia A and MSUD, and allogeneic cell therapy for Graft-vs-Host Disease in hematologic malignancies. Holding a tenured Professorship of Immunology at the University of Leon, Spain. Received PhD from the University of Wuerzburg, Germany and MD from the University of Salamanca, Spain
Author and co-author of over 100 peer-reviewed publications, including Nature, Lancet, Journal of Immunology and Journal of Experimental Medicine, books and medical articles and member of several scientific and medical societies.

Session Details:

Panel discussion: Evaluating current research and clinical trends in clinical operations for oncology trials

2024-04-23, 2:15 PM

Session Details:

Giving back to the community: Decentralized clinical trials and home nursing options to bring trials to patients’ home

2024-04-23, 12:30 PM

View In Agenda
Next speaker
Back
Mamta Thakker
Director of Clinical Operations, Pliant Therapeutics

Session Details:

Site management and site relationships in oncology trials

2024-04-23, 11:30 AM

Session Details:

Panel discussion: Building trust with patients in oncology clinical trials

2024-04-23, 2:15 PM

View In Agenda
Next speaker
Back
Jill Hacker
Director Data Management, Instil Bio

Jill Hacker has over 20 years of direct data management experience in the Biotechnology/Pharmaceutical Industry. She has worked on many Solid Tumor and Blood Related Cancer Clinical Trials over her career. She was part of the Rituxan and Zevalin approvals at IDEC Pharmaceuticals for Non-Hodgkin’s Lymphoma. Her biggest achievement to date has been in the Cell Therapy space where she was one of two data managers vital in obtaining accelerated approval for Yescarta in the United States and Europe. Yescarta is the first CAR T therapy approved for adults living with large B-cell Lymphoma. Jill earned her RN/BSN from Johns Hopkins School of Nursing and also has a Bachelor’s Degree from The University of Pennsylvania in The History and Sociology of Science.

Session Details:

PROBLEM-SOLVING ROUNDTABLE DISCUSSIONS

2024-04-24, 9:00 AM

View In Agenda
Next speaker
Back
Tariq Arshad
Chief Medical Officer, Qualigen Therapeutics

Dr. Arshad is an Oncologist, life sciences executive and biotechnology professional with 20+ years of strategic and operational experience in Immunology and Immuno-Oncology research, development and global product launch at blue-chip (Pfizer, Merck, Genentech, BD) and startup biotech companies. He has expertise in development and commercialization of transformative therapies & enabling technologies for severe, debilitating diseases, including hematological malignancies and solid tumors

Session Details:

Panel discussion: Evaluating current research and clinical trends in clinical operations for oncology trials

2024-04-23, 2:15 PM

Session Details:

Fireside chat: How to maintain a great relationship with CROs when running an oncology trial

2024-04-23, 5:15 PM

View In Agenda
Next speaker
Back
Radha Duttagupta
Vice President Clinical Affairs, Nucleix

Dr. Radha Duttagupta brings over 15 years of experience in test development, trial strategy and pre- and post-market studies for LDT/RUO/IVD products in the clinical diagnostic industry. Currently serving as the Vice President of Clinical Affairs at Nucleix, she is helping drive the clinical strategy around the development of a lung cancer screening test.

Prior to Nucleix, Radha served as Director of Clinical Operations and Clinical Development at Karius driving the clinical validity, utility and publication strategy for the Karius® Test (liquid biopsy for infectious diseases) in immunocompromised patients suspected with pneumonia. Radha has held previous positions at Cepheid (Danaher) leading clinical trials in the ID portfolio including Xpert® Xpress MVP, Xpert® MTB/XDR (molecular DST for Extreme Drug Resistance TB) and Affymetrix (part of Thermofisher Scientific) in product and clinical development of pre and post-natal tests for copy number (CN) detection spanning CytoScan™ XON, CytoScan™ Optima and CytoScan™ Dr. Radha has a Ph.D in Biochemistry and Molecular Genetics from Rutgers University and University of Medicine and Dentistry of New Jersey (UMDNJ), Robert Wood Johnson Medical School, New Jersey and was a post-doctoral fellow in the Transcriptome group at Affymetrix.

Session Details:

How are sponsors enhancing strategies for patient enrollment?

2024-04-23, 3:15 PM

View In Agenda
Next speaker
Back
Sonnika Lamont
Analyst, Clinical Trials Intelligence, GlobalData

Sonnika Lamont, MRes, is a a Clinical Trials Analyst at GlobalData, where her primary responsibilities include the review and update of clinical trial information presented on GlobalData’s Trials Intelligence Platform, the production of analytical reports and insights, testing database releases, and providing comprehensive conference coverage. She has a firm understanding of all aspects of clinical research, and the drug development process. Prior to joining GlobalData, Sonnika worked as a Clinical Trials Research Assistant at University College London’s Cancer Institute. Sonnika holds a Master of Research in Drug Design with a concentration in rare diseases from University College London, and a Bachelor of Science in Biochemistry from Nottingham Trent University.

Session Details:

Patient recruitment: Trends in trials that got it right

2024-04-24, 2:30 PM

View In Agenda
Next speaker
Back
Emily McInturf
Director Feasibility, PSI CRO

Emily McInturf, Director Feasibility, has worked in the clinical research industry for the past 15 years. As a leader within PSI’s global feasibility team, Emily specializes in strategy development across multiple therapeutic areas – focusing on aligning a study’s design with top enrolling investigators in the right countries.

Using PSI’s INTELIA platform, a machine-learning-powered system for data-driven feasibility and enrollment forecast, Emily models and compares hundreds of country and site combinations, their budgets and probability of success, ultimately recommending the most optimal enrollment scenario in line with each sponsor’s key objectives.

As a Director, Emily provides oversight for global feasibility and site identification activities for both pre- and post-award opportunities and projects.

Next speaker
Back
Chantalle Willie
Associate Director Feasibility & Client Success, Scimega

Chantalle Willie, B.Sc., CCRP, CIPP-C, Lean Certified, Associate Director Feasibility & Client Success, since 2019 she leads feasibility activities at Scimega using a data-driven approach and nurtures longstanding site network relations. Chantalle is an experienced Clinical Trial Specialist with a history of working in oncology research in various capacities, including site management, contracts, budgets, feasibility, and start-up. Also, a key member of the Scimega business development team, Chantalle received her B.Sc. from Western University with a Major in Medical Sciences, and her Lean Certification from the Lean Six Sigma Company, Canada. Chantalle is a certified Information Privacy Professional – Canada through the IAPP, and a member of the Society of Clinical Research Associates (SOCRA).

Next speaker
Back
Leslie Grimes
Executive Director, Project Delivery, ICON Biotech

Leslie brings a 360o perspective on clinical trials from her 20+ years of experience in the industry from academia to biotech, phase I unit to SMO oversight, and into the CRO world where she is currently a member of the ICON Biotech Oncology TA Leadership Team. She is passionate about partnering with biotech to model complementary supports for trial execution custom to each organization’s needs and ensuring equitable access to trials for all patients. Leslie holds a Master of Science in Biotechnology from The Johns Hopkins University and is the chair of ICON’s global Disability Awareness Network (DAWN) community group.

Session Details:

Maximizing the consultative partnership between CRO and biotech sponsors

2024-04-23, 10:30 AM

View In Agenda
Next speaker

Plan Your Visit

Venue

San Francisco Airport Marriott Waterfront

Accommodation

Please be aware that should you be contacted by any 3rd party housing companies that they are not affiliated with us or the hotel.

Sponsors

Select a sponsor to learn more

Featured Sponsors

Session Sponsors

Technology Spotlight Sponsor

Exhibitors

Co-Sponsors

Lanyard Sponsor

Why partner?

Contact us to become a partner

Partnership Opportunities

We work with you to design a bespoke package to meet your business needs, where you could:

  • Demonstrate your expertise on the agenda – have the attention of the entire audience. For greatest impact, why not position your talk before a networking break and immediately conduct follow up conversations with highly engaged attendees
  • Showcase your business and its services at an exhibition booth, which provides a perfect meeting place for prospective new clients
    Present the value proposition of your offering over your competitors, in front of an audience of active, engaged potential customers
  • Speak with key decision makers as part of our intimate, interactive roundtable style workshop sessions with over 8 hours allowed for networking

Event reach

  • 150+ attendees each year
  • 80% attendees C-suite level

 

Take a look at our current sponsors

Media Centre

MEDIA PARTNERS

Enquiry

Contact Us

SPONSORSHIP ENQUIRIES

Conor Taylor

Sponsorship Sales Manager

+44 (0) 20 7936 6870

SPEAKING OPPORTUNITIES

Zaynah Aslam

Conference Producer

MARKETING ENQUIRIES

Moona Popal

Marketing Manager

DELEGATE ENQUIRIES

Sunny Saikia

VIP Delegate Manager

SPONSORSHIP ENQUIRIES

To enquire about sponsorship opportunities for the conference, please contact:

Conor Taylor

Sponsorship Sales Manager


+44 (0)207 936 6870

SPEAKER ENQUIRES

To enquire about speaking opportunities for the conference, please contact:

Zaynah Aslam

Conference Producer


+44 20 4540 7613